Table 2.
Brief summarization of included patients
| Characteristics | 25 patients |
|---|---|
| Sex (male / female) | 13/12 |
| Median age (year) | 55 (7–83) |
| Underlying disease | 21 (0.84) |
| Pulmonary tuberculosis | 11 (0.44) |
| Pulmonary cystic fibrosis | 4 (0.16) |
| Bronchiectasis | 3 (0.12) |
| Previous diagnosis of S. apiospermum | 1 (0.04) |
| Pulmonary arterial hypertension | 1 (0.04) |
| Diabetes | 1 (0.04) |
| Previous tumor history | 1 (0.04) |
| Oral abscess | 1 (0.04) |
| No underlying disease | 4 (0.16) |
| Clinical manifestations | |
| Cough, Expectoration | 16 (0.64) |
| Hemoptysis | 12 (0.48) |
| Fever | 10 (0.40) |
| Dyspnea | 9 (0.36) |
| Night sweats | 3 (0.12) |
| Blood in sputum | 2 (0.08) |
| Weight loss | 3 (0.12) |
| Loss of appetite | 2 (0.08) |
| Chest pain | 2 (0.08) |
| Fatigue | 2 (0.08) |
| Pneumothorax | 1 (0.04) |
| Diagnosis time | |
| Misdiagnosed | 9 (0.36) |
| No misdiagnosis | 16 (0.64) |
| Diagnostic methods | |
| BALF culture | 13 (0.52) |
| Sputum culture | 7 (0.28) |
| Blood culture | 1 (0.04) |
| Lung biopsy tissue smear | 1 (0.04) |
| Lung biopsy tissue specimen culture | 2 (0.08) |
| Postoperative tissue culture | 4 (0.16) |
| DNA/RNA sequencing of BALF | 2 (0.08) |
| Lesion range | |
| Limited | 12 (0.48) |
| Extensive | 13 (0.52) |
| Treatment scheme | |
| Antifungal therapy | 15 (0.60) |
| Surgery treatment | 4 (0.16) |
| Antifungal + Surgery | 6 (0.24) |
| Prognosis | |
| Cure | 19 (0.76) |
| Improvement | 2 (0.08) |
| Death | 2 (0.08) |
| No mention | 2 (0.08) |